Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immature natural killer cells promote progression of triple-negative breast cancer.
Thacker G, Henry S, Nandi A, Debnath R, Singh S, Nayak A, Susnik B, Boone MM, Zhang Q, Kesmodel SB, Gumber S, Das GM, Kambayashi T, Dos Santos CO, Chakrabarti R. Thacker G, et al. Among authors: kesmodel sb. Sci Transl Med. 2023 Mar 8;15(686):eabl4414. doi: 10.1126/scitranslmed.abl4414. Epub 2023 Mar 8. Sci Transl Med. 2023. PMID: 36888695 Free PMC article.
Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy.
Mustafi S, Camarena V, Qureshi R, Sant DW, Wilkes Z, Bilbao D, Slingerland J, Kesmodel SB, Wang G. Mustafi S, et al. Among authors: kesmodel sb. Theranostics. 2021 Jan 20;11(8):3552-3564. doi: 10.7150/thno.53225. eCollection 2021. Theranostics. 2021. PMID: 33664847 Free PMC article.
Neighborhood Disadvantage and Breast Cancer-Specific Survival.
Goel N, Hernandez A, Thompson C, Choi S, Westrick A, Stoler J, Antoni MH, Rojas K, Kesmodel S, Figueroa ME, Cole S, Merchant N, Kobetz E. Goel N, et al. JAMA Netw Open. 2023 Apr 3;6(4):e238908. doi: 10.1001/jamanetworkopen.2023.8908. JAMA Netw Open. 2023. PMID: 37083666 Free PMC article.
Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes.
Friedman-Eldar O, Ozmen T, El Haddi SJ, Goel N, Tjendra Y, Kesmodel SB, Moller MG, Franceschi D, Layton C, Avisar E. Friedman-Eldar O, et al. Among authors: kesmodel sb. Ann Surg Oncol. 2022 Mar 18. doi: 10.1245/s10434-022-11473-9. Online ahead of print. Ann Surg Oncol. 2022. PMID: 35303178
54 results